| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 08/01/2002 | CA2431313A1 Methods of diagnosing colorectal cancer and/or breast cancer, compositions, and methods of screening for colorectal cancer and/or breast cancer modulators |
| 08/01/2002 | CA2431144A1 Cell adhesion proteins |
| 08/01/2002 | CA2430762A1 Colon cancer marker |
| 08/01/2002 | CA2429779A1 Adipocyte complement related protein zacrp13 |
| 08/01/2002 | CA2427647A1 Nucleic acid modification enzymes |
| 08/01/2002 | CA2426102A1 Method of diagnosing and treating cartilaginous disorders |
| 07/31/2002 | EP1227323A1 Non-A, non-B hepatitis virus antigen, diagnostic methods and vaccines |
| 07/31/2002 | EP1227159A1 Monoclonal antibody, hybridoma, immunoassay method and diagnosis kit |
| 07/31/2002 | EP1227154A2 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests |
| 07/31/2002 | EP1227152A1 Bacterial strain and genome of bifidobacterium |
| 07/31/2002 | EP1226441A1 Protein tyrosine kinase receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226435A1 Axor35, a g-protein coupled receptor |
| 07/31/2002 | EP1226276A2 Diagnostic test for cephalic pain |
| 07/31/2002 | EP1226267A1 Process for producing a product containing antihypertensive tripeptides |
| 07/31/2002 | EP1226264A2 Cell lines and constructs useful in production of e1-deleted adenoviruses in absence of replication competent adenovirus |
| 07/31/2002 | EP1226256A1 Recombinant therapeutic fusion proteins |
| 07/31/2002 | EP1226250A2 Gpcr-kd5 polypeptides and dna sequences thereof |
| 07/31/2002 | EP1226249A2 Follistatin-related protein zfsta4 |
| 07/31/2002 | EP1226248A1 Cloning, expression and characterisation of a gene expressed in tumour cells and involved in the regulation of the immune response |
| 07/31/2002 | EP1226247A1 Human gpr27-like g-protein coupled receptor polypeptide and polynucleotide sequences |
| 07/31/2002 | EP1226243A2 Nucleic acid molecules derived from rat brain and programmed cell death models |
| 07/31/2002 | EP1226231A1 19 human secreted proteins |
| 07/31/2002 | EP1226230A1 Lactobacillus helveticus producing antihypertensive di- and tripeptides |
| 07/31/2002 | EP1226178A1 Recombinant fusion molecules |
| 07/31/2002 | EP1226177A2 Anti-prostate stem cell antigen (psca) antibody compositions and methods of use |
| 07/31/2002 | EP1226175A1 Death domain-containing receptor polynucleotides, polypeptides, and antibodies |
| 07/31/2002 | EP1226174A1 Dna molecules encoding l-glutamate-gated chloride channels from schistocerca americana |
| 07/31/2002 | EP1226171A2 Novel germinal center kinase cell cycle proteins, compositions and methods of use |
| 07/31/2002 | EP1226169A2 Molecular structure of rhd negative locus |
| 07/31/2002 | EP1226161A2 Apo-2 receptor antibodies |
| 07/31/2002 | EP1226152A2 Regulation of gene expression by neuroleptic agents |
| 07/31/2002 | EP1154702B1 Method for preparing a protein isolate from a substance containing proteins |
| 07/31/2002 | EP0850244B1 Toxoplasma gondii glycoconjugates |
| 07/31/2002 | EP0804600B1 The cytoplasmic inhibition of gene expression |
| 07/31/2002 | EP0744955B1 Cyclic heptapeptide anti-inflammatory agent |
| 07/31/2002 | EP0708656B1 Immunogenic lhrh peptide constructs and synthetic universal immune stimulators for vaccines |
| 07/31/2002 | CN1361825A Novel antifungal agents and fungicides method for the production thereof and their use |
| 07/31/2002 | CN1361793A Expression and export of interferon-alpha proteins as Fc fusion proteins |
| 07/31/2002 | CN1361791A Process for deacylation of lipodepsipeptides |
| 07/31/2002 | CN1361181A New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 07/31/2002 | CN1361178A New recombinant blood coagulation factor VIII and its production process and medicinal composition |
| 07/31/2002 | CN1361177A New polypeptide human macro protein 11.11 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361176A New polypeptide human macro protein 12.43 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361175A New polypeptide human malformation syndrome associated protein PWWP9.24 and polynucleotides encoding this polypeptide |
| 07/31/2002 | CN1361174A Xuewang cell primary nerve nutrilite and its prepn |
| 07/31/2002 | CN1361131A Enhanced internal translation factor of eukaryotic cell and its use |
| 07/30/2002 | US6426411 PGC-1, a novel brown fat pparγ coactivator |
| 07/30/2002 | US6426405 Therapeutic target for treatment of diseases associated with altered muscle activity of pain transmission; has properties of glycine transporter associated with strychnine sensitive glycine receptors--properties called ?sc6? activity |
| 07/30/2002 | US6426217 MAGE-3 peptides presented by HLA class II molecules |
| 07/30/2002 | US6426214 Cell encapsulating device containing a cell displacing core for maintaining cell viability |
| 07/30/2002 | US6426204 Method for detecting candida infection |
| 07/30/2002 | US6426199 Isolated, purified nucleic acid detecting or isolating mutant forms of the dna molecules. |
| 07/30/2002 | US6426075 Genetic engineered polypeptide; killing cancer cells |
| 07/30/2002 | US6426073 Genetic engineered polypeptides |
| 07/30/2002 | US6426071 Administering protein c |
| 07/30/2002 | CA2237357C Stable biotinylated biomolecule composition and methods |
| 07/30/2002 | CA2084673C 16 kda surface protein of p.falciparum |
| 07/30/2002 | CA2039230C Monoclonal antibodies that inhibit growth of kaposi's sarcoma |
| 07/30/2002 | CA2029201C Process for purifying b pertussis antigens |
| 07/25/2002 | WO2002057794A2 Compositions and methods for detection of ehrlichia canis and ehrlichia chaffeensis antibodies |
| 07/25/2002 | WO2002057741A2 Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (sclc) |
| 07/25/2002 | WO2002057478A1 Methods and compositions for extracting proteins from cells |
| 07/25/2002 | WO2002057468A2 Method for secretory production of glycoprotein having human-type sugar chain using plant cell |
| 07/25/2002 | WO2002057460A2 Polynucleotides encoding human phosphatases |
| 07/25/2002 | WO2002057457A2 Human proteins 55562 and 21617, and methods of use thereof |
| 07/25/2002 | WO2002057454A2 Receptors and membrane-associated proteins |
| 07/25/2002 | WO2002057453A2 Polypetides and nucleic acids encoding same |
| 07/25/2002 | WO2002057451A1 Humanized polynucleotide sequence encoding renilla mulleri green fluorescent protein |
| 07/25/2002 | WO2002057444A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 07/25/2002 | WO2002057441A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2002 | WO2002057411A2 Hydrolase enzymes and their use in kinetic resolution |
| 07/25/2002 | WO2002057316A1 Novel monoclonal antibody |
| 07/25/2002 | WO2002057309A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/25/2002 | WO2002057226A2 68730 and 69112 protein kinase molecules and uses therefor |
| 07/25/2002 | WO2002056910A1 Binding domain-immunoglobulin fusion proteins |
| 07/25/2002 | WO2002056837A2 Inhibition of protein-phosphatases for the treatment of heart failure |
| 07/25/2002 | WO2002056829A2 Methods for preparing purified daptomycin |
| 07/25/2002 | WO2002040041A3 Orally ingestible preparation of mistletoe lectins and method |
| 07/25/2002 | WO2002020615A3 Antibody and/or chemokine constructs which bind to a chemokine receptor and their use in immunological disorders |
| 07/25/2002 | WO2002014489A3 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
| 07/25/2002 | WO2002010196A3 Identification of a novel glutamine transporter |
| 07/25/2002 | WO2002004496A3 Fimh adhesin proteins and methods of use |
| 07/25/2002 | WO2001094413A3 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 07/25/2002 | WO2001070798A3 Nusap, a novel gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent |
| 07/25/2002 | WO2001062929A3 Sodium/solute symporter-like protein and nucleic acids encoding same |
| 07/25/2002 | WO2001009187A9 Human monoclonal antibodies to her2/neu |
| 07/25/2002 | WO2001004157A9 NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS |
| 07/25/2002 | WO2001002567A9 16405 receptor, a g-protein coupled receptor |
| 07/25/2002 | WO2001000829A9 Human endogenous retrovirus in breast cancer |
| 07/25/2002 | US20020100066 Negative strand rna viral vector having autonomous replication capability |
| 07/25/2002 | US20020099199 Nucleotide sequences coding polypeptides for use in treatment of nervous system disorders; for use in learning enhancement |
| 07/25/2002 | US20020099191 EDG8 receptor, its preparation and use |
| 07/25/2002 | US20020099181 Anti-fibroblast growth factor-8 monoclonal antibody |
| 07/25/2002 | US20020099179 Genetically engineered antibodies for use in the treatment of immunological defects |
| 07/25/2002 | US20020099176 Antibodies to human g-protein chemokine receptor hdgnr10 (ccr5receptor) |
| 07/25/2002 | US20020099028 Genes and genetic elements associated with control of neoplastic transformation in mammalian cells |
| 07/25/2002 | US20020099016 Feed or food for vertebrates including humans for inhibiting diarrhea |
| 07/25/2002 | US20020099009 Also diagnosing or detecting apoptosis as well as antibodies directed against the protein. |
| 07/25/2002 | US20020098597 Antibodies to lipoproteins and apolipoproteins and methods of use thereof |
| 07/25/2002 | US20020098587 Dendritic cells; methods |